1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Solid Tumor Malignancies: new trials by email Literature Review of Solid Tumor Malignancies trials Research Report on Solid Tumor Malignancies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of Care Immunotherapies Nivolumab, Pembrolizumab - Solid Tumor Malignancies | Phase 3 | Recruiting | University of Kansas Medical Center | 192 | 2025-10-07 | 2026-07-01 |
Nivolumab (1) · pembrolizumab (1)
University of Kansas Medical Center (1)
United States (1)
Anup Kasi, MD (1)